文献速递骨质疏松与代谢性骨病创伤骨科

低钠血症与骨折:是否应将低钠血症作为潜在的生化危险因素进一步研究并纳入FRAX算法?

Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
PubMed 文献 · Osteoporos Int · 2017-01-10

FRAX®由世界卫生组织代谢性骨病合作中心开发,基于临床变量和股骨颈骨密度评估骨折风险,但未纳入生化指标。近期研究显示低钠血症与骨折发生相关;作者认为应进一步研究低钠血症作为骨骼骨折预测的生化危险因素,尤其针对髋部骨折,并提出了所需的大型队列数据要求。

要点

  • FRAX未纳入生化指标,因缺乏大型前瞻性研究验证。
  • 低钠血症是临床最常见的电解质异常,血钠测定可重复、经济且易获取。
  • 作者认为应进一步研究低钠血症作为骨折预测的生化危险因素,尤其针对髋部骨折。

核心结论

  • 作者认为低钠血症应作为骨骼骨折预测的生化危险因素进一步研究,尤其针对髋部骨折。

研究设计与样本

  • 本文为综述/观点文章,讨论FRAX工具的局限及将低钠血症纳入骨折预测模型所需的研究条件。

主要发现

  • FRAX基于临床变量和股骨颈骨密度评估骨折风险,其临床危险因素仅选择已确立且独立的骨骼骨折相关变量。
  • 近期有越来越多研究显示低钠血症与骨折发生之间存在关系。
  • 低钠血症是临床最常测得的电解质异常,血清钠浓度可重复、经济且易获取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • FRAX工具有若干局限性,其模型未纳入生化紊乱来评估骨折风险,因缺乏大型前瞻性研究验证。
  • 作者指出,将低钠血症纳入FRAX需收集来自不同地理位置的大型患者队列,除其他FRAX变量外还需包含血清钠测量,覆盖男女两性、广泛年龄范围和广泛地理代表性。
  • 还需纳入低钠血症持续时间和严重程度的数据,以及低钠血症发生和暴露时长相关的骨折风险、与FRAX其他危险变量的关系及其对死亡发生的独立影响(低钠血症增加死亡)的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Fracture Risk Assessment Tool (FRAX®) was developed by the WHO Collaborating Centre for metabolic bone diseases to evaluate fracture risk of patients. It is based on patient models that integrate the risk associated with clinical variables and bone mineral density (BMD) at the femoral neck. The clinical risk factors included in FRAX were chosen to include only well-established and independent variables related to skeletal fracture risk. The FRAX tool has acquired worldwide acceptance despite having several limitations. FRAX models have not included biochemical derangements in estimation of fracture risk due to the lack of validation in large prospective studies. Recently, there has been an increasing number of studies showing a relationship between hyponatremia and the occurrence of fractures. Hyponatremia is the most frequent electrolyte abnormality measured in the clinic, and serum sodium concentration is a very reproducible, affordable, and readily obtainable measurement. Thus, we think that hyponatremia should be further studied as a biochemical risk factor for skeletal fractures prediction, particularly those at the hip which carries the greatest morbidity and mortality. To achieve this will require the collection of large patient cohorts from diverse geographical locations that include a measure of serum sodium in addition to the other FRAX variables in large numbers, in both sexes, over a wide age range and with wide geographical representation. It would also require the inclusion of data on duration and severity of hyponatremia. Information will be required both on the risk of fracture associated with the occurrence and length of exposure to hyponatremia and to the relationship with the other risk variables included in FRAX and also the independent effect on the occurrence of death which is increased by hyponatremia.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Ayus JC, Bellido T, Negri AL, et al. Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms? Osteoporos Int. 2017. PMID: 28074251. doi:10.1007/s00198-017-3907-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。